Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

https://www.nature.com/articles/s42255-026-01514-y 27th April 2026

Article highlights & insights

Squamous cell carcinomas (SCCs) originate in epithelial tissues of older
individuals who have been exposed to environmental carcinogens. Despite
overlapping clinical hallmarks, SCCs from different anatomic sites have
different prognoses.

Here we show that fibroblasts confer site-specific cues that determine SCC proliferation and invasion. Oral and lung fibroblasts  have distinct lipid metabolism, transferring unique lipids to SCC cells that promote epithelial-to-mesenchymal transition, and oral and lung SCC  invasion. Whereas oral fibroblasts transfer sphingomyelins, which activate  the ceramide–sphingosine-1-phosphate–STAT3 pathway and promote oral  SCC invasion, lung fibroblasts transfer triglycerides to lung SCCs, thereby triggering cholesterol synthesis and invasion, which is associated with poor survival.

By contrast, dermal fibroblasts are lipid poor, and cutaneous SCC is less invasive. Our data indicate that targeting fibroblast lipid synthesis and SCC lipid uptake or breakdown inhibits oral and lung epithelial cancer invasion.

Filter by group
Filter by group leader
Filter by research topic
Filter by year
Search publications

https://www.nature.com/articles/s42255-026-01514-y

Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion

27 April 2026

Institute Authors (4)

Amaya Virós, Noah Palombo, Charlotte Russell, Claus Jørgensen

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00114-5

Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity

13 April 2026

Institute Authors (1)

Samra Turajlić

Research Group

Cancer Dynamics

array(1) { [0]=> int(8377) }

https://www.nature.com/articles/s41467-026-69964-2

Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response

25 February 2026

Institute Authors (1)

Sylvain Delaunay

Research Group

RNA Dynamics in Cancer

array(1) { [0]=> int(2224) }

https://doi.org/10.1038/s44161-025-00740-z

Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes

11 November 2025

Institute Authors (6)

Robert Sellers, John Weightman, Wolfgang Breitwieser, Natalia Moncaut, Michael Lie-a-ling, Georges Lacaud

Labs & Facilities

Computational Biology Support, Molecular Biology, Genome Editing and Mouse Models

array(3) { [0]=> int(3839) [1]=> int(3827) [2]=> int(2947) }

Research Group

Stem Cell Biology

array(1) { [0]=> int(2449) }

https://doi.org/10.1136/jitc-2025-012527

Systemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapy

31 October 2025

Institute Authors (4)

Isabella Mataloni, Antonia Banyard, Garry Ashton, Amaya Virós

Labs & Facilities

Mass and Flow Cytometry, Histology

array(2) { [0]=> int(2104) [1]=> int(3150) }

Research Group

Skin Cancer & Ageing

array(1) { [0]=> int(2344) }

https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-24-1224/766638/Glucocorticoids-Unleash-Immune-dependent-Melanoma

Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β Axis

15 October 2025

Institute Authors (12)

Charles Earnshaw, Poppy Dunn, Shih-Chieh Chiang, Maria Koufaki, Massimo Russo, Kimberley Hockenhull, Erin Richardson, Anna Pidoux, Alex Baker, Richard Reeves, Robert Sellers, Sudhakar Sahoo

Labs & Facilities

Computational Biology Support, Visualisation, Irradiation and Analysis

array(2) { [0]=> int(3839) [1]=> int(3154) }

Research Group

Cancer Inflammation and Immunity

array(1) { [0]=> int(1957) }